A Study to Compare the Pharmacokinetics of PF-06835919 in Participants With and Without Hepatic Impairment
A Study to Compare the Pharmacokinetics of PF-06835919 in Participants With and Without Hepatic Impairment. A Phase 1, Non-Randomized, Open-Label, Single-Dose Parallel-Cohort Study to Compare the Pharmacokinetics of PF-06835919 in Adult Participants With Varying Degrees of Hepatic Impairment Relative to Participants Without Hepatic Impairment.
Category & Conditions: Diabetes and Metabolic Disorders
Medicine: PF-06835919
ClinicalTrials.gov Identifier (NCT): NCT04193436
Protocol ID: C1061013
PrintDownloadOpen Plain Language Summary Result: Click here